500
Participants
Start Date
April 20, 2021
Primary Completion Date
July 22, 2024
Study Completion Date
July 22, 2024
Transcatheter Aortic Valve Implantation (TAVI)
Subjects will undergo TAVI
Medizinische Universitaet Vienna, Vienna
Universitaetsklinikum St. Poelten, Klinik fuer Innere Medizin 3, Sankt Pölten
LKH-Univ. Graz Klinik, Auenbruggerplaz 15, Graz
Universitatsspital Zurich, Zurich
Ospedale Mauriziano, Torino
Deutches Herzzentrum Berlin, Berlin
Complexo Hospitalario Universitario Coruna, A Coruña
Universitäres Herz- und Gefäßzentrum UKE Hamburg, Hamburg
UKSH University Hospital Kiel, Kiel
Hospital Universitario Clínico San Carlos, Madrid
Hospital Clinico Universitario Virgen de la Arrixaca, Murcia
Azienda ULSS2 Marca Trevigiana, Treviso
Hdz Bad Oeynhausen, Bad Oeynhausen
Clinique St Augustin, Bordeaux
Tampere University Hospital, Teiskontie 35, Tampere
CHU Bordeaux Hôpital Haut-Lévêque, Pessac
Hospital Alvara Cunqueiro, Estrada de Clara Campoamor 341, Vigo
Ospedale Civile Maggiore, Verona
Hospital Universitario Valdecilla Santander, Av. de Valdecilla 25, Santander
Hospital Universitaet Mainz, Mainz
CHU Hopital Charles Nicolle Rouen, Rouen
Azienda Ospedaliera Universitaria Federico II, Napoli
Deutsches Herzzentrum Muenchen, München
LMU, Klinikum der Universitaet Meunchen - Großhadern, München
Ospedale Moscati, Contrada Amoretta, Avellino
Irccs Ismett, Palermo
Institut Hospitalier Jacques Cartier Massy, Massy
Helsinki University Hospital, Helsinki
Ospedale San Camillo, Roma
Ospedale Santissima Annunziata, Sassari
Oslo Universitetssykehus Rikshospitalet, Oslo
Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental , Estrada do Forte do Alto do Duque, Lisbon
Hospital Santa Maria, Lisbon
Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia
Leeds General Infirmary, Leeds
St Thomas' Hospital, London
Oxford John Radcliffe Hospital, Oxford
Lead Sponsor
Edwards Lifesciences
INDUSTRY